Diplopia; an Adverse Effect of Citalopram
Citalopram, a selective serotonin reuptake inhibitor (SSRI), was approved by the Food and Drug Administration in 1998 as a safe and well-tolerated antidepressant; the use of it may result in rare and sometimes dangerous side effects. Diplopia is a rare adverse effect of citalopram that comes with do...
Main Authors: | Seyed Hamzeh Hosseini, Amirhossein Ahmadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2019-09-01
|
Series: | Pharmaceutical and Biomedical Research |
Subjects: | |
Online Access: | http://pbr.mazums.ac.ir/article-1-240-en.html |
Similar Items
-
Understanding and evaluating diplopia
by: Ani Sreedhar, et al.
Published: (2019-01-01) -
The use of citalopram for the treatment of cataplexy
by: Hassana de Almeida Fonseca, et al.
Published: (2014-03-01) -
Citalopram, depression and pseudo dementia: A neuropsychological case study Citalopram, depressão e pseudodemência: um estudo neuropsicológico de caso
by: Paulo Mattos
Published: (1995-12-01) -
Citalopram-induced Serotonin Syndrome: A Case Report
by: Wu-Pin Tseng, et al.
Published: (2005-07-01) -
Diplopia in Movement Disorders: A Systematic Review of the Literature
by: Larisa Ungureanu, et al.
Published: (2024-02-01)